Evaluation of selection criteria used in Alzheimer's disease clinical trials.

Abstract

BACKGROUND In the absence of a biological marker for Alzheimer's disease (AD), diagnosis has to be achieved using clinical criteria sets such as those outlined in DSM-IV, NINCDS-ADRDA, or ICD-10. As these criteria are quite broadly defined, there may be inter-rater variability in interpretation. METHODS Using a previously published CT scan measuring… (More)

Topics

Cite this paper

@article{Willmer1998EvaluationOS, title={Evaluation of selection criteria used in Alzheimer's disease clinical trials.}, author={John Willmer and Emma L Mohr}, journal={The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques}, year={1998}, volume={25 1}, pages={39-43} }